SARS-CoV-2 vaccination strategies : Should the extended dosing interval strategy be implemented in future pandemics?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Travel medicine and infectious disease - 56(2023) vom: 07. Nov., Seite 102650 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Valderrama-Beltrán, Sandra [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 16.12.2023 Date Revised 11.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.tmaid.2023.102650 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363064842 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363064842 | ||
| 003 | DE-627 | ||
| 005 | 20240311231920.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.tmaid.2023.102650 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1323.xml |
| 035 | |a (DE-627)NLM363064842 | ||
| 035 | |a (NLM)37813321 | ||
| 035 | |a (PII)S1477-8939(23)00110-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Valderrama-Beltrán, Sandra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 vaccination strategies |b Should the extended dosing interval strategy be implemented in future pandemics? |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2023 | ||
| 500 | |a Date Revised 11.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Cuervo-Rojas, Juliana |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez-Vernaza, Samuel |e verfasserin |4 aut | |
| 700 | 1 | |a Alvarez-Moreno, Carlos A |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez-Morales, Alfonso J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Travel medicine and infectious disease |d 2003 |g 56(2023) vom: 07. Nov., Seite 102650 |w (DE-627)NLM16457655X |x 1873-0442 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2023 |g day:07 |g month:11 |g pages:102650 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tmaid.2023.102650 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2023 |b 07 |c 11 |h 102650 | ||